UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION

                     Washington, D. C. 20549

                          _____________

                            FORM 8-K

                         CURRENT REPORT

             Pursuant to Section 13 or 15(d) of the

                 Securities Exchange Act of 1934


Date of earliest event
  reported:  January 22, 2007


                         AMR Corporation
     (Exact name of registrant as specified in its charter)


            Delaware           1-8400                  75-1825172
    (State of Incorporation)(Commission File Number) (IRS Employer
                                                   Identification No.)


4333 Amon Carter Blvd.      Fort Worth, Texas              76155
 (Address of principal executive offices)              (Zip Code)


                            (817) 963-1234
                       (Registrant's telephone number)



   (Former name or former address, if changed since last report.)



Check  the  appropriate  box below if  the  Form  8-K  filing  is
intended to simultaneously satisfy the filing obligation  of  the
registrant under any of the following provisions:

[ ]  Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))



Item 1.01.  Entry into a Material Definitive Agreement.

On  January 22, 2007, AMR Corporation (the Company), entered into
an  Underwriting  Agreement  (the  Underwriting  Agreement)  with
Credit  Suisse Securities (USA) LLC, acting on behalf  of  itself
and  the  other  underwriters  named therein  (the  Underwriters)
relating  to  the  issuance and sale of  13,000,000  shares  (the
1/22/07  Shares) of the Company's common stock, par  value  $1.00
per  share (the Common Stock), at an offering price to the public
of $38.70 per share.  The Company has granted the Underwriters  a
30-day  option  to  purchase an additional  1,950,000  shares  of
Common  Stock (together with the 1/22/07 Shares, the Shares),  at
the  same  price  per share paid to the Company for  the  1/22/07
Shares,  to  cover over-allotments, if any.  The closing  of  the
offering,  which is subject to customary closing  conditions,  is
expected to occur on January 26, 2007.

The  Shares  will  be  issued pursuant  to  the  Company's  shelf
registration statement (the Registration Statement) on  Form  S-3
(File  Nos. 333-136563 and 333-136563-01), which became effective
upon filing with the Securities and Exchange Commission on August
11, 2006.

The  Underwriting  Agreement is filed  as  Exhibit  1.1  to  this
Current Report on Form 8-K (this report), and the description  of
the material terms of the Underwriting Agreement is qualified  in
its  entirety by reference to such exhibit.  For a more  detailed
description  of  the Underwriting Agreement, see  the  disclosure
under  the  caption  "Underwriting" contained  in  the  Company's
Prospectus  Supplement dated January 22, 2007 to  the  Prospectus
dated  August  11, 2006, each of which has been  filed  with  the
Securities and Exchange Commission pursuant to Rule 424(b)  under
the  Securities  Act, which disclosure is hereby incorporated  by
reference.   The  Underwriting  Agreement  is  also  filed   with
reference  to, and is hereby incorporated by reference into,  the
Registration  Statement.  A copy of the opinion  of  Debevoise  &
Plimpton LLP, relating to the legality of the Shares is filed  as
Exhibit 5.1 to this report and is filed with reference to, and is
hereby   incorporated   by  reference  into,   the   Registration
Statement.   A  copy of the opinion of Debevoise &  Plimpton  LLP
relating  to  certain tax matters with respect to the  Shares  is
filed  as  Exhibit 8.1 to this report and is filed with reference
to,   and   is  hereby  incorporated  by  reference   into,   the
Registration Statement.


Item 9.01.  Financial Statements and Exhibits.

       (d) Exhibits

     1.1  Underwriting Agreement dated January 22, 2007 between AMR
          Corporation and Credit Suisse Securities (USA) LLC, acting on
          behalf of itself and the other underwriters named therein

     5.1  Opinion of Debevoise & Plimpton LLP

     8.1  Opinion of Debevoise & Plimpton LLP

    23.1  Consent  of  Debevoise & Plimpton LLP  (contained  in
          Exhibit 5.1)

    23.2  Consent  of  Debevoise & Plimpton LLP  (contained  in
          Exhibit 8.1)






                            SIGNATURE



     Pursuant to the requirements of the Securities Exchange  Act
of  1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


                                        AMR CORPORATION



                                        /s/ Kenneth W. Wimberly
                                        Kenneth W. Wimberly
                                        Corporate Secretary



Dated:  January 24, 2007

                          EXHIBIT INDEX


Exhibit        Description


1.1       Underwriting  Agreement dated January 22, 2007  between
          AMR Corporation and Credit Suisse Securities (USA) LLC,
          acting  on  behalf of itself and the other underwriters
          named therein

5.1       Opinion of Debevoise & Plimpton LLP

8.1       Opinion of Debevoise & Plimpton LLP

23.1      Consent of Debevoise & Plimpton LLP (contained in
          Exhibit 5.1)

23.2      Consent  of  Debevoise & Plimpton  LLP  (contained  in
          Exhibit 8.1)